PAT-DX3-MMAE significantly increases survival in animal model of breast cancer Oct. 18, 2021 No Comments
Targinta selects TARG-10 as lead drug candidate for triple-negative breast cancer Oct. 18, 2021 No Comments
Discovery of novel peptides that upregulate costimulatory and checkpoint pathways Oct. 18, 2021 No Comments
Engineered microbial therapy for local metabolic modulation of the tumor microenvironment Oct. 14, 2021 No Comments
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent ADCs including B7-H3 antibodies Oct. 13, 2021 No Comments
DPX-SurMAGE dual T-cell therapy targeting MAGE-A9 and survivin shows promise in animal studies Oct. 11, 2021 No Comments
SG-3-00802 shows encouraging preclinical activity in combination with anti-PD-1 therapy Oct. 8, 2021 No Comments
RSS